Home » Topics » BioWorld

BioWorld
RSS

CBOE ADDS CENTOCOR TO OPTIONS LIST

Jan. 20, 1992

BIOCYTE RAISES $2.1 MILLION

Jan. 20, 1992

GENETICS INSTITUTE OFF MIDCAP 400

Jan. 20, 1992

BTGC'S GROWTH HORMONE APPROVED IN U.K.

Jan. 17, 1992

GENENTECH REPORTS PROFIT FOR YEAR

Jan. 17, 1992

IG TO ACQUIRE TESTING COMPANY

Jan. 17, 1992

STOCKS SLUMP FOR SECOND DAY

Jan. 17, 1992

GI SHAREHOLDERS OK MERGER WITH AHP

Jan. 17, 1992

FDA PANEL RECOMMENDS ONCOSCINT

Jan. 17, 1992

IDEC GETS APPROVAL FOR ANTI-ID TRIALS

Jan. 17, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Harbour Biomed closes busy year with $1B+ BMS deal
BioWorld
Harbour Biomed has added another collaboration to its end-of-year dealmaking, this time with Bristol Myers Squibb Co. (BMS) to develop multispecific antibodies....
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...